Trial Outcomes & Findings for The Effect of Acute Intermittent Hypoxia on Motor Learning (NCT NCT05341466)

NCT ID: NCT05341466

Last Updated: 2025-05-14

Results Overview

Transcranial magnetic stimulation (TMS) can be applied over the primary motor cortex to examine changes in corticospinal excitability. The downstream muscle activation can be recorded with surface EMG as a motor-evoked potential (MEP). The peak-to-peak MEP amplitude (mV) is as an index of corticospinal excitability. A randomized sequence of TMS intensities can be applied over the primary motor cortex, ranging from 90-140% of the participants' resting motor threshold (RMT). The mean MEP amplitude will be plotted against the corresponding stimulation intensity to produce the recruitment curve. The area under the recruitment curve is an additional index of corticospinal excitability (mV/% RMT).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

56 participants

Primary outcome timeframe

We will measure TMS before the start of 5 consecutive days of AIH or SHAM treatment. We will measure TMS within 24 hours of the final treatment.

Results posted on

2025-05-14

Participant Flow

Individuals were recruited through advertisements in Colorado, with recruitment occurring from May 2022 through January 2025. A total of 56 participants were enrolled across both studies. Part 1: Motor Learning (N = 30) \& Part 2: Corticospinal Indices of Motor Learning (N = 26).

Participants were randomly assigned to their respective groups and completed either AIH, SHAM, or no treatment before undergoing motor learning assessments using a split-belt treadmill paradigm. Qualifying participants also received corticospinal excitability assessments using transcranial magnetic stimulation (TMS).

Participant milestones

Participant milestones
Measure
Repetitive Acute Intermittent Hypoxia
5 consecutive days of 15, 1.5 min episodes at 9% O2 (AIH) alternating with 21% O2 at 1 min intervals
SHAM Acute Intermittent Hypoxia
5 consecutive days of 15, 1.5 min episodes at 21% O2 (SHAM AIH) alternating with 21% O2 at 1 min intervals
Control Group
No AIH or SHAM exposure
Overall Study
STARTED
28
13
15
Overall Study
COMPLETED
28
13
15
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

The Effect of Acute Intermittent Hypoxia on Motor Learning

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Repetitive Acute Intermittent Hypoxia
n=28 Participants
5 consecutive days of 15, 1.5 min episodes at 9% O2 (AIH) alternating with 21% O2 at 1 min intervals
SHAM Acute Intermittent Hypoxia
n=13 Participants
5 consecutive days of 15, 1.5 min episodes at 21% O2 (SHAM AIH) alternating with 21% O2 at 1 min intervals
Control Group
n=15 Participants
No AIH or SHAM exposure
Total
n=56 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=85 Participants
1 Participants
n=18 Participants
2 Participants
n=39 Participants
3 Participants
Age, Categorical
Between 18 and 65 years
28 Participants
n=85 Participants
12 Participants
n=18 Participants
13 Participants
n=39 Participants
53 Participants
Age, Categorical
>=65 years
0 Participants
n=85 Participants
0 Participants
n=18 Participants
0 Participants
n=39 Participants
0 Participants
Sex: Female, Male
Female
16 Participants
n=85 Participants
6 Participants
n=18 Participants
8 Participants
n=39 Participants
30 Participants
Sex: Female, Male
Male
12 Participants
n=85 Participants
7 Participants
n=18 Participants
7 Participants
n=39 Participants
26 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=85 Participants
0 Participants
n=18 Participants
0 Participants
n=39 Participants
0 Participants
Race (NIH/OMB)
Asian
0 Participants
n=85 Participants
0 Participants
n=18 Participants
1 Participants
n=39 Participants
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=85 Participants
0 Participants
n=18 Participants
0 Participants
n=39 Participants
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=85 Participants
0 Participants
n=18 Participants
1 Participants
n=39 Participants
1 Participants
Race (NIH/OMB)
White
26 Participants
n=85 Participants
12 Participants
n=18 Participants
13 Participants
n=39 Participants
51 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=85 Participants
1 Participants
n=18 Participants
0 Participants
n=39 Participants
3 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=85 Participants
0 Participants
n=18 Participants
0 Participants
n=39 Participants
0 Participants

PRIMARY outcome

Timeframe: We will measure TMS before the start of 5 consecutive days of AIH or SHAM treatment. We will measure TMS within 24 hours of the final treatment.

Population: A total of 56 participants were enrolled for this study: Part 1: Motor Learning (N = 30; AIH group + control group) \& Part 2: Corticospinal Indices of Motor Learning (N = 36; AIH group + SHAM group). Changes in corticospinal excitability reflect the results from Part 2 of the study, which consisted of an AIH group and a SHAM group (i.e., blinded normoxia).

Transcranial magnetic stimulation (TMS) can be applied over the primary motor cortex to examine changes in corticospinal excitability. The downstream muscle activation can be recorded with surface EMG as a motor-evoked potential (MEP). The peak-to-peak MEP amplitude (mV) is as an index of corticospinal excitability. A randomized sequence of TMS intensities can be applied over the primary motor cortex, ranging from 90-140% of the participants' resting motor threshold (RMT). The mean MEP amplitude will be plotted against the corresponding stimulation intensity to produce the recruitment curve. The area under the recruitment curve is an additional index of corticospinal excitability (mV/% RMT).

Outcome measures

Outcome measures
Measure
Repetitive Acute Intermittent Hypoxia
n=13 Participants
5 consecutive days of 15, 1.5 min episodes at 9% O2 (AIH) alternating with 21% O2 at 1 min intervals
SHAM Acute Intermittent Hypoxia
n=13 Participants
5 consecutive days of 15, 1.5 min episodes at 21% O2 (SHAM AIH) alternating with 21% O2 at 1 min intervals
Change in Corticospinal Excitability
0.528 mV*percentage of RMT
Standard Error 0.188
0.132 mV*percentage of RMT
Standard Error 0.188

PRIMARY outcome

Timeframe: We will compare asymmetry 15 minutes after the final AIH treatment to asymmetry following no treatment (control group).

Population: A total of 56 participants were enrolled for this study: Part 1: Motor Learning (N = 30; AIH group + control group) \& Part 2: Corticospinal Indices of Motor Learning (N = 36; AIH group + SHAM group). Changes in step length asymmetry reflect the results from Part 1 of the study, which consisted of an AIH group and a control group.

Step length asymmetry will be quantified as the ratio of the normalized difference in step lengths between the fast and slow legs during split-belt motor adaptation: (Fast leg - Slow leg step length) / (Fast leg + Slow leg step length).

Outcome measures

Outcome measures
Measure
Repetitive Acute Intermittent Hypoxia
n=15 Participants
5 consecutive days of 15, 1.5 min episodes at 9% O2 (AIH) alternating with 21% O2 at 1 min intervals
SHAM Acute Intermittent Hypoxia
n=15 Participants
5 consecutive days of 15, 1.5 min episodes at 21% O2 (SHAM AIH) alternating with 21% O2 at 1 min intervals
Step Length Asymmetry
-0.052 Ratio
Standard Deviation 0.023
-0.0478 Ratio
Standard Deviation 0.024

PRIMARY outcome

Timeframe: We will compare asymmetry 15 minutes after the final AIH treatment to asymmetry following no treatment (control group).

Population: A total of 56 participants were enrolled for this study: Part 1: Motor Learning (N = 30; AIH group + control group) \& Part 2: Corticospinal Indices of Motor Learning (N = 36; AIH group + SHAM group). Changes in step time asymmetry reflect the results from Part 1 of the study, which consisted of an AIH group and a control group.

Step time asymmetry will be quantified as the ratio of the normalized difference in step times between the fast and slow legs during split-belt motor adaptation: (Fast leg - Slow leg step time) / (Fast leg + Slow leg step time).

Outcome measures

Outcome measures
Measure
Repetitive Acute Intermittent Hypoxia
n=15 Participants
5 consecutive days of 15, 1.5 min episodes at 9% O2 (AIH) alternating with 21% O2 at 1 min intervals
SHAM Acute Intermittent Hypoxia
n=15 Participants
5 consecutive days of 15, 1.5 min episodes at 21% O2 (SHAM AIH) alternating with 21% O2 at 1 min intervals
Step Time Asymmetry
0.0781 Ratio
Standard Deviation 0.021
0.0681 Ratio
Standard Deviation 0.0252

PRIMARY outcome

Timeframe: We will compare net metabolic power 15 minutes after the final AIH treatment to asymmetry following no treatment (control group).

Population: A total of 56 participants were enrolled for this study: Part 1: Motor Learning (N = 30; AIH group + control group) \& Part 2: Corticospinal Indices of Motor Learning (N = 36; AIH group + SHAM group). Changes in net metabolic power reflect the results from Part 1 of the study, which consisted of an AIH group and a control group. One participant was excluded from metabolic analysis due to RER \> 1.0, violating assumption that primarily oxidative pathways were being utilized.

Using expired gas analyses, we will calculate net metabolic power by inputting steady-state values for V̇O₂ and V̇CO₂ into standard regression equations (W), subtracting resting values, and normalizing the result to each participant's body weight (kg).

Outcome measures

Outcome measures
Measure
Repetitive Acute Intermittent Hypoxia
n=15 Participants
5 consecutive days of 15, 1.5 min episodes at 9% O2 (AIH) alternating with 21% O2 at 1 min intervals
SHAM Acute Intermittent Hypoxia
n=15 Participants
5 consecutive days of 15, 1.5 min episodes at 21% O2 (SHAM AIH) alternating with 21% O2 at 1 min intervals
Net Metabolic Power
3.87 W/kg
Standard Deviation 0.397
4.27 W/kg
Standard Deviation 0.766

Adverse Events

Repetitive Acute Intermittent Hypoxia

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

SHAM Acute Intermittent Hypoxia

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Andrew Q. Tan

University of Colorado, Boulder

Phone: 303-735-0259

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place